Addiction Biology | September 22, 2022

Clergue-Duval, Virgile, Vrillon, Agathe, Jeanblanc, Jérôme, Questel, Frank, Azuar, Julien, Fouquet, Grégory, Mouton-Liger, François, Rollet, Dorian, Hispard, Eric, Bouaziz-Amar, Elodie, Bloch, Vanessa, Dereux, Alexandra, Cognat, Emmanuel, Marie-Claire, Cynthia, Laplanche, Jean-Louis, Bellivier, Frank, Paquet, Claire, Naassila, Mickael and Vorspan, Florence

Addiction Biology, Wiley, 2022, 27 (6)

https://dx.doi.org/10.1111/adb.13232

Abstract

 In this translational study, we investigated the plasma tau protein, neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCHL1), which are established biomarkers of neurological injury, as predictive biomarkers of alcohol withdrawal-associated brain toxicity. In the clinical study, patients with severe alcohol use disorder (AUD) on D1 of hospitalization for alcohol cessation (AC) (N = 36) were compared to severe AUD patients with at least 3 months of abstinence (N = 16). Overall, patients were 40 men (76.9%), aged 49.8 years [SD +/- 9.9]. Tau, NfL, GFAP and UCHL1 levels were measured using SIMOA and analysed with a quasipoisson regression model adjusted for age and sex. The NfL level was higher in the AC group (p = 0.013). In the AC group, the tau (p = 0.021) and UCHL1 (p = 0.021) levels were positively associated with the dose of diazepam per weight, and the tau (p = 0.045), NfL (p = 4.9 x 10(-3)) and UCHL1 (p = 0.036) levels were higher in the presence of signs of Wernicke’s encephalopathy (n = 9). In the preclinical study, NfL and GFAP levels were assessed in the alcohol deprivation effect (ADE) procedure (N = 17) and control Wistar rats (N = 15). Furthermore, ADE rats were prospectively assessed: after 24 h (T1) and 3 weeks of AC (T2) (paired-samples Wilcoxon and Mann-Whitney tests). The NfL level was higher in the ADE model than in the control rats at both T1 and T2 (p = 0.033 and p = 1.3 x 10(-3)) and higher at T2 than at T1 (p = 0.040). Plasma tau, NfL and UCHL1 are potential biomarkers of brain suffering during alcohol withdrawal.